Workflow
CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01
Globenewswire· 2025-10-01 12:00
CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced the initiation of toxicology studies conducted under Good Laboratory Practice (GLP) standards for its lead product candidate, CMP-S ...
SRx Health Solutions Appoints Joshua Epstein to Board of Directors and Compensation Committee
Globenewswire· 2025-10-01 12:00
TAMPA, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced the appointment of Joshua Epstein to the Board of Directors and Compensation Committee. Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” ...
Integral Metals Corp. Provides Comprehensive Analysis of Soil Geochemical Survey at the KAP Project
Globenewswire· 2025-10-01 12:00
Over 2,000 soils analyzed; 818 B-horizon samples returned multiple anomalies with scores up to 11CALGARY, Alberta, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to report the completion and compilation of its 2025 soil geochemistry survey at the KAP Project, located in the Mackenzie Mountains, Northwest Territories. The program was designed to systematically evaluate near-surface geochemical responses in the vicinity of t ...
Alignment Health Unveils 2026 Medicare Advantage Plans with Strong Benefits, Expanded Support for Seniors
Globenewswire· 2025-10-01 12:00
Plans to reach nearly 8.3 million Medicare-eligible adults across five states during annual enrollment period, Oct. 15-Dec. 7ORANGE, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning Medicare Advantage (MA) plan from Alignment Health, today announced its 2026 product portfolio, offering 68 plan options across 45 counties in five states. The plans are designed to deliver consistent value, broad coverage and support for seniors’ diverse health needs. Medicare’s annual enrollmen ...
Asia Broadband Finalizes Milestone Production Agreement For Second Large-Scale Gold and Silver Ore Stockpile in Mexico
Globenewswire· 2025-10-01 12:00
LAS VEGAS, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company has finalized the terms of another historic and long-term processing and production agreement for a large-scale gold and silver ore stockpile in Etzatlan, Jalisco, Mexico. The estimated gold and silver ore value of this second stockpile agreement exceeds the value of the Company’s first stockpile agreement completed in December 2022. AABB management is thrilled to re ...
Global Uranium Corp. Announces Plans for Fieldwork in Wyoming, USA
Globenewswire· 2025-10-01 12:00
Initial Field Program to Assess Radiometric Trends and Identify High-Priority Uranium TargetsCALGARY, Alberta, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Global Uranium Corp. (CSE: GURN | OTC: GURFF | FRA: Q3J) (the “Company”) is pleased to announce its intention to initiate fieldwork on the Airline Project, located in the Copper Mountain District of Wyoming. The program will be designed to advance the Company’s understanding of surface radiometric signatures and provide the foundation for follow-up exploration. The ...
Abacus Asset Group to Host Investor Summit on Longevity-Based Investments and Private Credit in Zurich, Switzerland with Global Virtual Access
Globenewswire· 2025-10-01 12:00
ORLANDO, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL), a leader in the alternative asset management space, announced today that its specialized division, Abacus Asset Group, will host an Investor Summit on Tuesday, October 28, 2025, at The Dolder Grand in Zurich, Switzerland. The event will highlight the secondary life insurance industry, lifespan-based financial products, and private credit opportunities, offering both in-person and virtua ...
Aeries Technology Delivers ~30% Faster Development Cycles Through AI-Enabled Engineering
Globenewswire· 2025-10-01 12:00
AI-led application modernization drives client-wide expansion interest, supports repeatable engineering transformation playbookNEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Aeries Technology, Inc. (NASDAQ: AERT), a global leader in AI-powered business transformation and Global Capability Center (GCC) services, today announced the successful completion of an AI-driven application modernization engagement with a high-transaction digital platform provider. Aeries deployed AI-based software development and testin ...
Exceeding Beyond Expectations: Unlock Your Way with VOOPOO DRAG S3 & DRAG X3
Globenewswire· 2025-10-01 12:00
SHENZHEN, China, Oct. 01, 2025 (GLOBE NEWSWIRE) -- VOOPOO proudly introduces the next evolution in vaping excellence: DRAG S3 and DRAG X3. Both devices share a unified CMF design yet are tailored for distinctly different users. The DRAG S3 delivers a maximum power of 60W in a compact form with a built-in battery, making it ideal for MTL users. Its counterpart, the DRAG X3, offers a maximum power of 80W high output and supports an external battery, catering to DTL enthusiasts. Flexible Power Options to Suit ...
Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee (DSMC) to Accelerate 177Lu-RAD202 Phase 1 ‘HEAT’ Dose Escalation Clinical Trial
Globenewswire· 2025-10-01 12:00
Phase 1 study to progress to the next dose level of 75mCi in patients with HER2+ advanced solid tumors, instead of the protocol-planned dose of 40mCiSYDNEY, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX: RAD, Nasdaq: RADX, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, today announced that it has received a positive recommendation from the Data Safety and Monitori ...